BusinessEmerald Health Pharmaceuticals Granted FDA Orphan Drug Designation for Systemic SclerodermaBy Nasdaq OMXOct 20, 2017, 11:00 AM UTC
BusinessFate Therapeutics Receives FDA Orphan Drug Designation for ProTmune™ in Allogeneic Hematopoietic Cell TransplantationBy Nasdaq OMXSep 26, 2016, 12:00 PM UTC